Advertisement

Topics

FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment

18:15 EDT 21 Jun 2017 | Kaiser Health News

Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.

Original Article: FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment

NEXT ARTICLE

More From BioPortfolio on "FDA Ruling On Aussie Biotech Could Boost Congressman’s Investment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...